Clinical Impact of Adherence to NCCN Guidelines for Biomarker Testing and First-Line Treatment in Advanced Non-Small Cell Lung Cancer (aNSCLC) Using Real-World Electronic Health Record Data

被引：0
作者：
Ani John
Baiyu Yang
Roma Shah
机构：
[1] Roche Diagnostics,
来源：
Advances in Therapy | 2021年 / 38卷
关键词：
Adherence; Biomarker; First-line treatment; Guidelines; Non-small cell lung cancer; Precision medicine;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1552 / 1566
页数：14
相关论文
共 50 条
  • [21] Pembrolizumab in Combination with Chemotherapy as First-Line Treatment of Advanced Non-Small Cell Lung Cancer
    Jahan, N.
    Swarup, S.
    Sultan, A.
    Naing, T.
    Mogollon-Duffo, F.
    Ball, S.
    Tun, A.
    Htut, T.
    Dash, A.
    D'Cunha, N.
    Hardwicke, F.
    Awasthi, S.
    Tijani, L.
    Thein, K.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S917 - S918
  • [22] Determining Line of Therapy from Real-World Data in Non-Small Cell Lung Cancer
    Grady, Connor B.
    Hwang, Wei-Ting
    Reuss, Joshua E.
    Iams, Wade
    Cass, Amanda
    Liu, Geoffrey
    Patel, Devalben
    Liu, Stephen V.
    Montenegro, Gabriela Liliana Bravo
    Patil, Tejas
    Nieva, Jorge J.
    Herrmann, Amanda
    Marrone, Kristen A.
    Lam, Vincent K.
    Schwartzman, William
    Dowell, Jonathan
    Villaruz, Liza C.
    Miller, Kelsey Leigh
    Weiss, Jared
    Sun, Fangdi
    Velcheti, Vamsidhar
    Camidge, D. Ross
    Aggarwal, Charu
    Sun, Lova
    Marmarelis, Melina E.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2024, 33 (12)
  • [23] Real-world data on the first-line immune checkpoint inhibitors or in combination with chemotherapy in older patients (aged ≥ 75 years) with advanced non-small cell lung cancer
    Zhang, Panpan
    Ma, Minting
    Nie, Jun
    Dai, Ling
    Hu, Weiheng
    Zhang, Jie
    Wu, Di
    Chen, Xiaoling
    Ma, Xiangjuan
    Tian, Guangming
    Han, Sen
    Long, Jieran
    Wang, Yang
    Zhang, Ziran
    Hao, Qianyun
    Fang, Jian
    HELIYON, 2024, 10 (04)
  • [24] Real-world study of lazertinib as second-line or greater treatment in advanced non-small cell lung cancer
    Lim, Jeong Uk
    Kim, Kyuhwan
    Kim, Kyu Yean
    Kang, Hye Seon
    Shin, Ah. Young
    Yeo, Chang Dong
    Kim, Sung Kyoung
    Park, Chan Kwon
    Lee, Sang Haak
    Kim, Seung Joon
    THORACIC CANCER, 2024, 15 (19) : 1513 - 1521
  • [25] Time on Treatment of First-Line PD-1 Inhibitor Monotherapy for Metastatic Non-Small Cell Lung Cancer Patients: Real-World Experience Data
    Apter, L.
    Moser, S. Sharman
    Chandwani, S.
    Chen, X.
    Shalev, V.
    Chodick, G.
    Siegelmann-Danieli, N.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S920 - S920
  • [26] Real-World Outcomes and Treatments Patterns Prior and after the Introduction of First-Line Immunotherapy for the Treatment of Metastatic Non-Small Cell Lung Cancer
    Danesi, Valentina
    Massa, Ilaria
    Foca, Flavia
    Delmonte, Angelo
    Crino, Lucio
    Bronte, Giuseppe
    Ragonesi, Maria
    Maltoni, Roberta
    Manunta, Silvia
    Cravero, Paola
    Andrikou, Kalliopi
    Priano, Ilaria
    Balzi, William
    Gentili, Nicola
    Burke, Thomas
    Altini, Mattia
    CANCERS, 2022, 14 (18)
  • [27] Circulating Osteopontin Predicts Clinical and Radiological Response in First-Line Treatment of Advanced Non-Small Cell Lung Cancer
    Ramoni, Davide
    Coco, Simona
    Rossi, Giovanni
    Dellepiane, Chiara
    Bennicelli, Elisa
    Santamaria, Sara
    Zinoli, Linda
    Tagliafico, Alberto Stefano
    Tagliamento, Marco
    Barletta, Giulia
    Liberale, Luca
    Tirandi, Amedeo
    Minetti, Silvia
    Bertolotto, Maria
    Montecucco, Fabrizio
    Genova, Carlo
    Carbone, Federico
    LUNG, 2024, 202 (02) : 197 - 210
  • [28] Real-world treatment and survival of patients with advanced non-small cell lung Cancer: a German retrospective data analysis
    Hardtstock, Fraence
    Myers, David
    Li, Tracy
    Cizova, Diana
    Maywald, Ulf
    Wilke, Thomas
    Griesinger, Frank
    BMC CANCER, 2020, 20 (01)
  • [29] Real-world treatment and survival of patients with advanced non-small cell lung Cancer: a German retrospective data analysis
    Fränce Hardtstock
    David Myers
    Tracy Li
    Diana Cizova
    Ulf Maywald
    Thomas Wilke
    Frank Griesinger
    BMC Cancer, 20
  • [30] First-Line Treatment of Metastatic Non-Small Cell Lung Cancer in the Elderly
    Losanno, Tania
    Gridelli, Cesare
    CURRENT ONCOLOGY REPORTS, 2021, 23 (10)
12345